on ABL DIAGNOSTICS (EPA:ABLD)
ABL Diagnostics Announces General Meeting on June 30, 2026
ABL Diagnostics has informed shareholders of the upcoming Ordinary and Extraordinary General Meeting scheduled for June 30, 2026. The meeting will be held at the law firm De Gaulle Fleurance & Associates in Paris and will begin at 11:00 a.m. It will address topics such as the annual financial statements for the fiscal year ending December 31, 2025.
The agenda, resolution texts, and procedures for participation and voting have been detailed in the preliminary notice published in the Bulletin des Annonces Légales Obligatoires (BALO) on May 22, 2026. Shareholders can access all related documents on ABL Diagnostics' official website.
These documents are available under legal and regulatory conditions for further consultation, offering shareholders comprehensive insights into the proceedings and decisions to be made at this crucial meeting.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ABL DIAGNOSTICS news